Vivo Capital, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.4T
Holdings
54
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (54 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 1,797,745 | $265.9B | 19.06% | |
| 2 | LEGNLegend Biotech Corp Sponsored | 3,555,007 | $151.3B | 10.85% | |
| 3 | —New Frontier Health Corp | 14,300,000 | $118.4B | 8.49% | |
| 4 | —Genetron Holdings Ltd | 6,339,860 | $76.5B | 5.49% | |
| 5 | PASGPassage Bio Inc | 2,229,587 | $60.9B | 4.37% | |
| 6 | AMRSEURAmyris, Inc | 10,181,472 | $43.5B | 3.12% | |
| 7 | CRNXCrinetics Pharmaceuticals Inc | 2,316,628 | $40.6B | 2.91% | |
| 8 | ARQTArcutis Biotherapeutics Inc | 1,289,360 | $39.0B | 2.80% | |
| 9 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 2.74% | |
| 10 | OPHTEURIveric Bio Inc | 5,966,527 | $30.4B | 2.18% | |
| 11 | KNSAKiniksa Pharmaceuticals | 1,151,622 | $29.3B | 2.10% | |
| 12 | AVDLAvadel Pharmaceuticals PLC | 3,526,093 | $28.5B | 2.04% | |
| 13 | —Kadmon Holdings Inc | 5,347,768 | $27.4B | 1.96% | |
| 14 | —Zymeworks Inc | 734,161 | $26.5B | 1.90% | |
| 15 | ARWRArrowhead Pharmaceuticals Inc | 576,505 | $24.9B | 1.79% | |
| 16 | —Sierra Oncology, Inc | 1,917,074 | $23.2B | 1.66% | |
| 17 | TCE2Celldex Therapeutics Inc | 1,600,000 | $20.8B | 1.49% | |
| 18 | IM8NInsmed Inc | 800,000 | $19.5B | 1.40% | |
| 19 | RCKTRocket Pharmaceuticals Inc | 860,648 | $18.0B | 1.29% | |
| 20 | KALVKalVista Pharmaceuticals Inc. | 1,476,796 | $17.9B | 1.28% | |
| 21 | —Zogenix Inc | 658,523 | $17.8B | 1.28% | |
| 22 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $17.2B | 1.23% | |
| 23 | KURAKura Oncology Inc | 1,050,000 | $17.1B | 1.23% | |
| 24 | CDXSCodexis, Inc | 1,493,903 | $17.0B | 1.22% | |
| 25 | —Myokardia Inc | 158,310 | $15.3B | 1.10% | |
| 26 | AKROAkero Therapeutics Inc | 591,169 | $14.7B | 1.06% | |
| 27 | SG7Sage Therapeutics Inc | 343,179 | $14.3B | 1.02% | |
| 28 | —Calliditas Therapeutics AB | 580,000 | $13.5B | 0.96% | |
| 29 | FIXXEURHomology Medicines, Inc. | 875,696 | $13.3B | 0.95% | |
| 30 | —Aduro Biotech Inc | 5,118,560 | $11.8B | 0.85% | |
| 31 | LRMRLarimar Therapeutics Inc | 799,662 | $10.3B | 0.74% | |
| 32 | ZLABZai Lab Limited | 122,107 | $10.0B | 0.72% | |
| 33 | 1K0IGM Biosciences Inc | 119,480 | $8.7B | 0.63% | |
| 34 | MTNBEURMatinas Biopharma Hldgs Inc | 11,279,323 | $8.7B | 0.63% | |
| 35 | KALAKala Pharmaceuticals, Inc. | 786,883 | $8.3B | 0.59% | |
| 36 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $8.1B | 0.58% | |
| 37 | VSTMVerastem Inc | 4,639,535 | $8.0B | 0.57% | |
| 38 | ORTXUSDOrchard Therapeutics plc | 1,325,736 | $8.0B | 0.57% | |
| 39 | CBAYUSDCymabay Therapeutics Inc | 2,089,356 | $7.3B | 0.52% | |
| 40 | VRNAVerona Pharma PLC | 1,492,951 | $7.0B | 0.50% | |
| 41 | SELBUSDSelecta Biosciences Inc | 2,255,781 | $6.4B | 0.46% | |
| 42 | BDTXBlack Diamond Therapeutics Inc | 150,349 | $6.3B | 0.45% | |
| 43 | —Menlo Therapeutics Inc. | 3,643,824 | $6.3B | 0.45% | |
| 44 | RVMDRevolution Medicines Inc | 199,518 | $6.3B | 0.45% | |
| 45 | 1T7Tricida, Inc. | 174,764 | $4.8B | 0.34% | |
| 46 | MEIPUSDMEI Pharma Inc | 1,082,080 | $4.5B | 0.32% | |
| 47 | —Avrobio Inc | 253,625 | $4.4B | 0.32% | |
| 48 | —Constellation Pharmaceutical | 140,298 | $4.2B | 0.30% | |
| 49 | GLMDGalmed Pharmaceuticals Ltd | 860,103 | $4.1B | 0.29% | |
| 50 | ATRCAtricure Inc | 64,573 | $2.9B | 0.21% | |
| 51 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $2.7B | 0.19% | |
| 52 | MREOMereo Biopharma Group PLC | 778,000 | $2.4B | 0.17% | |
| 53 | —DBV Technologies S.A. | 269,995 | $1.2B | 0.08% | |
| 54 | DTILPrecision Biosciences Inc | 140,255 | $1.2B | 0.08% |